Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study

Trial Profile

Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study

Discontinued
Phase of Trial: Phase II

Latest Information Update: 09 Oct 2015

At a glance

  • Drugs Aramchol (Primary)
  • Indications Cholelithiasis
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Galmed Pharmaceuticals
  • Most Recent Events

    • 02 Oct 2015 Status changed from recruiting to discontinued as per ClinicalTrials.gov record.
    • 13 May 2015 According to a Galmed media release, the enrolment pace of the trial has tracked significantly slower than anticipated. Therefore, the company decided to expand the trial into 3 additional centers. However, enrolment has still continued to disappoint. Therefore, the company has filed a request with the principal investigator to cease enrollment in the underperforming center. The company is taking this opportunity to reexamine the study design in order to achieve a better recruitment.
    • 05 Jan 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top